Close Menu

In a paper published online in advance in Nature this week, investigators at the Centre for Lymphoid Cancers and the Centre for Translational and Applied Genomics in Vancouver report their use of RNA-seq to show that a gene fusion involving the major histocompatibility complex class II transactivator CIITA occurs frequently in lymphoid cancers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.